Skip to main content

Oculis Holding AG

corporate_fare Company Profile

Oculis Holding AG

OCS·NASDAQ·Life Sciences·CIK 0001953530

Oculis Holding AG is a global late clinical-stage biopharmaceutical company. The company was incorporated under Swiss law on October 31, 2022, and is registered with the commercial register of the Canton of Zug under company registration number CHE-396.695.611. Its principal executive office is located at Bahnhofstrasse 20, CH-6300, Zug, Switzerland. Oculis Holding AG specializes in developing innovative drug candidates for neuro-ophthalmic and ophthalmic diseases. The company has operations in Switzerland, the U.S., and Iceland, and aims to become a global leader in neuro-ophthalmic and ophthalmic therapeutics.

Oculis Holding AG (NASDAQ:OCS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 20 items for OCS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for OCS spans 6-K, F-3ASR, 20-F.

Recent high-impact activity:

  • FDA Clears IND, Opening Acute MS Relapse Path for Privosegtor
  • Oculis Q3 Loss Widens to CHF 18.2M as Expenses Climb; Cash Runs Into 2H 2029
  • Oculis Upsizes ATM to $125M and Posts Narrower Q3 Loss With Runway Into 2H 2029
  • Oculis Secures Full Worldwide Rights to Privosegtor, Eliminating Legacy Royalties
  • Oculis Buys Out Privosegtor Rights from Accure for $3.8M Cash and 2M Shares, Ending Royalty Obligations

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$98.96M
Diluted EPS
-$1.89
Op. Cash Flow
-$66.3M
Free Cash Flow
-$66.61M
Operating Income
-$81.67M
Cash & Equivalents
$81.33M
Debt / Equity
0.00×
Source: 20-F · filed 2026-03-04 · accession 0001193125-26-091446

Short Interest & Short Volume

5.64 days to cover

FINRA reported short interest of 1,583,743 shares in OCS as of the October 30, 2026 settlement, a 11.3% decrease from the prior period — about 5.6 days to cover at its recent average daily volume. On November 20, 2026, 52.2% of OCS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,583,743 shares as of October 30, 2026
Change vs prior period▼ 11.3%
Days to cover5.64 at avg daily volume of 280,834
Daily short volume (FINRA facilities)52.2% of 115,239 shares on November 20, 2026
5-day average short volume43.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for OCS, detected from its recent SEC filings · based on capital-structure filings through 2026-11-03.

1 recent capital raise

ATM Capacity Raised to $125 Million · $61.3 Million Already Sold Under Prior ATM

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Insider Transactions

OCS files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with O →
$7.06
52-week range · as of 2026-11-03 $7.06 – $34.48
Market cap
$435.83M
Volume
235.2K (0.8× avg)
3-mo avg 313.4K
Live data · 2026-11-22 10:00 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed OCS - Latest Insights

OCS
Nov 16, 2026, 2:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.64
Real-time Price: $7.06 info
Change: -$0.580 (-8%) info
Market Cap: $435.828M info
OCS
Nov 03, 2026, 4:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $7.89
Real-time Price: $7.06 info
Change: -$0.833 (-11%) info
Market Cap: $435.828M info
OCS
Nov 03, 2026, 4:15 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $7.89
Real-time Price: $7.06 info
Change: -$0.833 (-11%) info
Market Cap: $435.828M info
OCS
Aug 10, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $12.98
Real-time Price: $7.06 info
Change: -$5.92 (-46%) info
Market Cap: $435.828M info
OCS
Aug 10, 2026, 3:01 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $12.68
Real-time Price: $7.06 info
Change: -$5.62 (-44%) info
Market Cap: $435.828M info
OCS
Aug 06, 2026, 4:32 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $12.38
Real-time Price: $7.06 info
Change: -$5.32 (-43%) info
Market Cap: $435.828M info
OCS
Aug 03, 2026, 4:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $11.25
Real-time Price: $7.06 info
Change: -$4.19 (-37%) info
Market Cap: $435.828M info
OCS
Jun 02, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $13.94
Real-time Price: $7.06 info
Change: -$6.88 (-49%) info
Market Cap: $435.828M info
OCS
May 29, 2026, 5:54 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $14.30
Real-time Price: $7.06 info
Change: -$7.24 (-51%) info
Market Cap: $435.828M info
OCS
May 29, 2026, 3:01 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $22.71
Real-time Price: $7.06 info
Change: -$15.65 (-69%) info
Market Cap: $435.828M info
OCS
May 14, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $30.22
Real-time Price: $7.06 info
Change: -$23.16 (-77%) info
Market Cap: $435.828M info
OCS
May 11, 2026, 4:07 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $32.65
Real-time Price: $7.06 info
Change: -$25.59 (-78%) info
Market Cap: $435.828M info
OCS
May 11, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $32.65
Real-time Price: $7.06 info
Change: -$25.59 (-78%) info
Market Cap: $435.828M info
OCS
May 07, 2026, 4:57 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $29.58
Real-time Price: $7.06 info
Change: -$22.52 (-76%) info
Market Cap: $435.828M info
OCS
Apr 21, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $27.38
Real-time Price: $7.06 info
Change: -$20.32 (-74%) info
Market Cap: $435.828M info
OCS
Mar 31, 2026, 4:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $24.40
Real-time Price: $7.06 info
Change: -$17.34 (-71%) info
Market Cap: $435.828M info
OCS
Mar 04, 2026, 4:31 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $27.72
Real-time Price: $7.06 info
Change: -$20.66 (-75%) info
Market Cap: $435.828M info
OCS
Mar 04, 2026, 4:19 PM EST
Filing Type: F-3ASR
Importance Score:
7
Price at Filing: $27.85
Real-time Price: $7.06 info
Change: -$20.79 (-75%) info
Market Cap: $435.828M info
OCS
Mar 04, 2026, 4:01 PM EST
Filing Type: 20-F
Importance Score:
8
Price at Filing: $27.72
Real-time Price: $7.06 info
Change: -$20.66 (-75%) info
Market Cap: $435.828M info
OCS
Mar 03, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $28.38
Real-time Price: $7.06 info
Change: -$21.32 (-75%) info
Market Cap: $435.828M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets